Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 47.5K | Jun 12, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 12.5K | May 5, 2023 | Direct | ||
Molecular Templates, Inc. | Director | Stock Option (right to buy) | 1K | Oct 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
MTEM | Molecular Templates, Inc. | Oct 27, 2023 | 1 | $0 | 4 | Oct 31, 2023 | Director |
MTEM | Molecular Templates, Inc. | Aug 31, 2023 | 1 | $0 | 4 | Aug 31, 2023 | Interim Chief Medical Officer, Director |
TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
APRE | Aprea Therapeutics, Inc. | May 5, 2023 | 1 | $0 | 4 | May 8, 2023 | Director |
APRE | Aprea Therapeutics, Inc. | May 5, 2023 | 0 | $0 | 3 | May 8, 2023 | Director |
MTEM | Molecular Templates, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
TCRX | TScan Therapeutics, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
MTEM | Molecular Templates, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
MTEM | Molecular Templates, Inc. | Mar 1, 2022 | 0 | $0 | 3 | Mar 2, 2022 | Director |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 2 | $0 | 4 | Jul 16, 2021 | Director |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 15, 2021 | Director |